AI assistant
Sending…
iBio, Inc. — Director's Dealing 2012
Jun 29, 2012
35045_dirs_2012-06-29_7e95aa4e-029c-4911-b4c1-6bab8b60976e.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: iBio, Inc. (IBIO)
CIK: 0001420720
Period of Report: 2012-06-27
Reporting Person: KAY E GERALD (10% Owner)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2012-06-27 | Common Stock | S | 150000 | $0.76 | Disposed | 4119803 | Direct |
Footnotes
F1: Shares disposed of in connection with a refinancing transaction involving Integrated BioPharma, Inc., the former parent company of the Issuer. The Reporting Person has no present intent to dispose of additional shares.
More from iBio, Inc.
Regulatory Filings
2026
Apr 29
Regulatory Filings
2026
Apr 8
Director's Dealing
2026
Mar 23
Director's Dealing
2026
Mar 23
Regulatory Filings
2026
Feb 27
Regulatory Filings
2026
Feb 27
Major Shareholding Notification
2026
Feb 17
Major Shareholding Notification
2026
Feb 17
Major Shareholding Notification
2026
Feb 17
Interim / Quarterly Report
2026
Feb 10